Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lansoprazole Delayed release Capsules bulk supplier for pharma manufacturers

Lansoprazole Delayed Release Capsules 15 mg and 30 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 15 mg and 30 mg

Reference Brands: Prevacid(US & EU)

Category: Gastrointestinal Drugs

Lansoprazole 15 mg and 30 mg delayed-release capsules containing enteric-coated granules, a finished proton pump inhibitor product. For importers, distributors, pharmacies and hospital buyers seeking registered supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Lansoprazole Delayed Release Capsules? List it or send an offer →

Product Description:

Lansoprazole is a benzimidazole proton pump inhibitor. Activated in the acid of the parietal cell, it binds irreversibly to the acid pump until new pumps are made. This page covers 15 mg and 30 mg delayed-release capsules, the finished dosage form ready for the patient. Each hard capsule contains enteric-coated granules that survive stomach acid and dissolve in the intestine. The 15 mg strength mostly serves maintenance and the 30 mg healing courses.

Doctors prescribe lansoprazole capsules for duodenal and gastric ulcers, gastro-oesophageal reflux and erosive oesophagitis, ulcers associated with NSAIDs, Helicobacter pylori triple therapy and Zollinger-Ellison syndrome. A dose is taken once daily before breakfast. Patients who cannot swallow a capsule may open it and sprinkle the granules on soft food, provided the granules are not chewed. Rilpivirine should not be co-prescribed, and absorption of atazanavir falls. Lansoprazole can raise tacrolimus and methotrexate levels. Long-term use brings the usual PPI cautions on magnesium, vitamin B12 and bone fractures.

Sourcing notes. Most markets keep these capsules on prescription. Request a CTD or ACTD dossier with bioequivalence and dissolution testing in acid followed by buffer. The drug degrades with heat, light and moisture, so look for alu-alu blisters or desiccated bottles and stability data at 30 °C/75% RH for Zone IVb destinations. Storage is at room temperature, with no cold chain. Ask for the batch CoA, a GMP certificate and a CoPP. When you enquire, give the strength, capsule colour if your registration fixes it, pack size and market.

Lansoprazole Delayed Release Capsules — third party manufacturing & bulk supply

Lansoprazole Delayed Release Capsules 15 mg and 30 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lansoprazole Delayed Release Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lansoprazole Delayed Release Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lansoprazole Delayed Release Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Lansoprazole Delayed release Capsules is listed as Capsules in 15 mg and 30 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lansoprazole Delayed release Capsules is referenced against Prevacid(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Rabeprazole Sodium Tablets

Strength:
20 mg and 40 mg

Form: Tablets

Reference Brands: AcipHex(US & EU)

View Details
Dexlansoprazole Capsules

Strength:
30 mg and 60 mg

Form: Capsules

Reference Brands: Dexilant(US & EU)

View Details
Esomeprazole Magnesium Capsules

Strength:
20 mg, 40 mg

Form: Capsules

Reference Brands: Nexium(US & EU)

View Details
Nizatidine Capsules

Strength:
150 mg

Form: Capsules

Reference Brands: Axid(US & EU)

View Details
Mebeverine Tablets and Capsules

Strength:
135 mg tablets and 200 mg Capsules

Form: Tablets and capsules

Reference Brands: Duspatalin(EU)

View Details
Hyoscine Butylbromide Tablet

Strength:
10 mg

Form: Tablets

Reference Brands: Buscopan(EU)

View Details
Otilonium Bromide Tablets

Strength:
40 mg

Form: Tablets

Reference Brands: Spasmomen(EU)

View Details
Mesalamine (5-ASA) Tablets

Strength:
400 mg, 500 mg, and 1 g

Form: Tablets

Reference Brands: Asacol HD, Pentasa (US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us